By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and New England Biolabs announced on Tuesday a non-exclusive licensing agreement for the commercialization of the Gibson Assembly Master Mix.

The deal calls for NEB to commercialize the product, which is based on the Gibson Assembly method, developed by Daniel Gibson and colleagues at the J. Craig Venter Institute as part of a program sponsored by Synthetic Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.